摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-[[4-[2-[(3-Methylpyridin-2-yl)amino]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione

中文名称
——
中文别名
——
英文名称
5-[[4-[2-[(3-Methylpyridin-2-yl)amino]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione
英文别名
——
5-[[4-[2-[(3-Methylpyridin-2-yl)amino]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione化学式
CAS
——
化学式
C18H19N3O3S
mdl
——
分子量
357.4
InChiKey
LGBNWRQGHSQFKT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.3
  • 重原子数:
    25
  • 可旋转键数:
    7
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.28
  • 拓扑面积:
    106
  • 氢给体数:
    2
  • 氢受体数:
    6

文献信息

  • METHODS OF TREATING OR PREVENTING COGNITIVE IMPAIRMENT USING INDANE ACETIC ACID DERIVATIVES BASED ON APOE4 GENOTYPE
    申请人:T3D Therapeutics, Inc.
    公开号:US20180153859A1
    公开(公告)日:2018-06-07
    The present invention provides indane acetic acid and their derivatives and methods for the treating and/or preventing of cognitive disorders based on the ApoE4 genotype of human subjects.
    本发明提供了关于人类主体的ApoE4基因型的吲哌乙酸及其衍生物的治疗和/或预防认知障碍的方法。
  • [EN] METHODS OF TREATING OR PREVENTING PSORIASIS, AND/OR ALZHEIMER'S DISEASE USING INDANE ACETIC ACID DERIVATIVES<br/>[FR] PROCÉDÉ DE TRAITEMENT PRÉVENTIF OU CURATIF DU PSORIASIS ET/OU DE LA MALADIE D'ALZHEIMER AU MOYEN DE DÉRIVÉS INDANE D'ACIDE ACÉTIQUE
    申请人:DARA BIOSCIENCES INC
    公开号:WO2010141696A1
    公开(公告)日:2010-12-09
    The present invention provides indane acetic acid and their derivatives and methods for the treating and/or preventing psoriasis and/or Alzheimer's diseases.
    本发明提供了茚乙酸及其衍生物,以及用于治疗和/或预防牛皮癣和/或阿尔茨海默病的方法。
  • METHODS OF DOSE ADMINISTRATION FOR TREATING OR PREVENTING COGNITIVE IMPAIRMENT USING INDANE ACETIC ACID DERIVATIVES
    申请人:T3D Therapeutics, Inc.
    公开号:US20180153860A1
    公开(公告)日:2018-06-07
    The present invention provides indane acetic acid and their derivatives and methods for the treating and/or preventing of cognitive disorders.
    本发明提供了茚乙酸及其衍生物,以及用于治疗和/或预防认知障碍的方法。
  • Biaromatic ligand activators of PPARgamma receptors
    申请人:——
    公开号:US20030134885A1
    公开(公告)日:2003-07-17
    Novel pharmaceutical/cosmetic compositions contain at least one biaromatic ligand activator of a PPAR&ggr; receptor, such biaromatic ligand having the structural formula (I): 1 and are well suited, inter alia, for regulating and/or restoring skin lipid metabolism, for treating a wide variety of dermatological afflictions, and for preventing and/or treating the signs of aging and/or dry skin.
    新型的制药/化妆品组合物至少包含一种PPAR&ggr;受体的双芳香配体激活剂,该双芳香配体具有结构式(I):1,并且非常适合调节和/或恢复皮肤脂质代谢,治疗各种皮肤病症,以及预防和/或治疗衰老和/或干燥皮肤的迹象。
  • [EN] NOVEL BIAROMATIC COMPOUNDS THAT ACTIVATE PPAR TYPE RECEPTORS, AND USE THEREOF IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS<br/>[FR] NOUVEAUX COMPOSES BIOAROMATIQUES ACTIVANT DES RECEPTEURS DE TYPE PPAR, ET LEUR UTILISATION DANS DES COMPOSITIONS PHARMACEUTIQUES OU COSMETIQUES
    申请人:GALDERMA RES & DEV
    公开号:WO2006018326A1
    公开(公告)日:2006-02-23
    The invention relates to novel biaromatic compounds that correspond to the general formula (I) and also to the method for preparing them, and to their use in pharmaceutical compositions for use in human or veterinary medicine (in dermatology, and also in the field of cardiovascular diseases, immune diseases and/or lipid metabolism-related diseases), or alternatively in cosmetic compositions.
    该发明涉及与一般式(I) 相对应的新型双芳香化合物,以及其制备方法,以及它们在制药组合物中的应用,用于人类或兽医药物(在皮肤科、心血管疾病、免疫疾病和/或脂质代谢相关疾病领域),或者用于化妆品组合物。
查看更多